You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Somatostatin receptor imaging

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • FDG-PET
  • Galium-68 DOTATATE
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

Enrolling by invitation
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumor Grade 1
  • Iowa City, Iowa
    The University of Iowa
Dec 9, 2022

Neuroendocrine Tumors Trial in Edmonton (68Ga-HA-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Edmonton, Alberta, Canada
    University of Alberta
Apr 11, 2022

Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

Not yet recruiting
  • Neuroendocrine Tumors
  • Somatostatin Receptor-positive Neuroendocrine Tumor
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin - Madison
Nov 2, 2023

Somatostatin Receptor Imaging in Cardiac Sarcoidosis

Withdrawn
  • Cardiac Sarcoidosis
  • Cu-64 DOTATATE
  • Copenhagen, Denmark
    Rigshospitalet
Oct 12, 2020

Neuroendocrine Tumors Trial in Leuven (Al18F-NOTA-octreotide, PET/CT, PET/MR)

Completed
  • Neuroendocrine Tumors
  • Leuven, Belgium
    Universitaire Ziekenhuizen Leuven
Feb 16, 2022

Metastatic Neuroendocrine Tumor Trial (Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate)

Not yet recruiting
  • Metastatic Neuroendocrine Tumor
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Feb 10, 2023

Small Cell Lung Cancer and Breast Cancer Trial in Worldwide (Satoreotide tetraxetan, Satoreotide trizoxetan)

Terminated
Has Results
  • Small Cell Lung Cancer and Breast Cancer
  • Satoreotide tetraxetan
  • Satoreotide trizoxetan
  • Houston, Texas
  • +7 more
Aug 22, 2022

Myocarditis Trial in Vandoeuvre/les/nancy (DOTATOC-68Ga PET initial, DOTATOC-68Ga PET at 6 months, blood sample)

Recruiting
  • Myocarditis
  • DOTATOC-68Ga PET initial
  • +2 more
  • Vandoeuvre/les/nancy, France
    Véronique ROCH
Aug 3, 2021

PET Imaging in Patients With Suspected Cardiac Sarcoidosis

Recruiting
  • Cardiac Sarcoidosis
  • Gallium-68 DOTATATE
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 4, 2021

Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

Recruiting
  • Lung Cancer
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022

Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • +4 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jan 14, 2023

Somatostatin Receptor Imaging in Nasopharyngeal Cancer

Completed
  • Nasopharyngeal Carcinoma
    • Singapore, Singapore
      National Cancer Centre
    Apr 29, 2020

    Somatostatin Receptors and GH Receptor Expression on Bone of

    Completed
    • Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
    • Trans-sphenoidal surgery
    • Roma, Italy
      Fondazione Policlinnico Gemelli IRCCS
    Apr 6, 2023

    Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)

    Recruiting
    • Neuroendocrine Neoplasm
    • Biospecimen Collection
    • +4 more
    • Duarte, California
    • +3 more
    Jan 12, 2023

    Sarcoidosis Trial in Boston (Indium-111 Pentreotide, Gallium-68 DOTATATE)

    Completed
    Has Results
    • Sarcoidosis
    • Indium-111 Pentreotide
    • Gallium-68 DOTATATE
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Apr 2, 2020

    Neuroendocrine Tumor, Liver Metastases, Neuroendocrine Gastroenteropancreatic Tumour Trial in France (Positron emission

    Recruiting
    • Neuroendocrine Tumor
    • +2 more
    • Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection
    • +3 more
    • Bordeaux, France
    • +3 more
    Nov 18, 2021

    Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +6 more
    • Vancouver, British Columbia, Canada
      BC Cancer
    Aug 19, 2022

    Neuroendocrine Tumors Trial in Worldwide (177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, CAPTEM (Capecitabine

    Recruiting
    • Neuroendocrine Tumors
    • 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT
    • +4 more
    • Palo Alto, California
    • +30 more
    Dec 14, 2022

    Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +3 more
    • 90Y-DOTA tyr3-Octreotide
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Oct 6, 2022

    Adult Medulloblastoma, Childhood Medulloblastoma, Neuroblastoma Trial in Iowa City (drug, procedure, radiation)

    Completed
    Has Results
    • Adult Medulloblastoma
    • +4 more
    • gallium Ga 68-edotreotide
    • +4 more
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Aug 26, 2021

    Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

    Not yet recruiting
    • Neuroendocrine Tumors
    • Lutetium[177Lu] Oxodotreotide Injection
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    May 30, 2023

    Hepatocellular Carcinoma Trial in Birmingham ([68Ga]DOTATATE-PET/MRI)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • Birmingham, Alabama
      University of Alabama at Birmingham Medical Center
    Dec 16, 2022

    Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)

    Active, not recruiting
    • Neuroendocrine Carcinoma
    • Lu-DOTA-TATE
    • London, Ontario, Canada
      London Health Sciences Centre
    Apr 5, 2022